calcium phosphate, monobasic, anhydrous has been researched along with fibrin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Makowski, GS; Ramsby, ML | 2 |
| Arnold, U; Lindenhayn, K; Perka, C; Spitzer, RS | 1 |
3 other study(ies) available for calcium phosphate, monobasic, anhydrous and fibrin
| Article | Year |
|---|---|
Amorphous calcium phosphate-mediated binding of matrix metalloproteinase-9 to fibrin is inhibited by pyrophosphate and bisphosphonate.
Topics: Binding, Competitive; Calcium Phosphates; Diphosphates; Diphosphonates; Fibrin; Humans; Macromolecular Substances; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Protein Binding | 1999 |
The use of fibrin beads for tissue engineering and subsequential transplantation.
Topics: Alginates; Animals; Aprotinin; Biocompatible Materials; Biomedical Engineering; Calcium Phosphates; Cell Differentiation; Cell Division; Cell Transplantation; Cells, Cultured; Chondrocytes; Extracellular Matrix; Fibrin; Fibrinogen; Glucuronic Acid; Growth Substances; Hexuronic Acids; Hyaluronic Acid; Intervertebral Disc; Microspheres; Periosteum; Polymers; Rabbits; Swine | 2001 |
Interaction of amorphous calcium phosphate with fibrin in vitro causes decreased fibrinolysis and altered protease profiles: implications for atherosclerotic disease.
Topics: Aged; Aged, 80 and over; Arteriosclerosis; Calcium Phosphates; Caseins; Coronary Artery Bypass; Endopeptidases; Fibrin; Fibrinolysis; Gelatin; Humans; Male; Plasminogen Activators; Protein Binding | 2001 |